1Ballen K K,Becker P S,et al.Autologous stem-cell transplantation can be performed safely without the use of blood-product support.J Clin Oncol,2004,22:4087-4094.
2Sands B E,Winston B D,et al.Randomized,controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease.Aliment Pharmacol Ther,2002,16:399-406.
3Ellis M,Zwaan F,Hedstrom U,et al.Recombinant human interleukin 11 and bacterial infection in patients with[correction of] haematological malignant disease undergoing chemotherapy:a double-blind placebo-controlled randomised trial.Lancet,2003,361(9354):275-280.
4Dickinson E C,Tuncer R,et al.Recombinant human interleukin-11 prevents mucosal atrophy and bowel shortening in the defunctionalized intestine.J Pediatr Surg,2000,35:1079-1083.
5Lgssiar A,Hassan M,et al.Interleukin-11 inhibits NF-kappaB and AP-1 activation in islets and prevents diabetes induced with streptozotocin in mice.Exp Biol Med (Maywood),2004,229(5):425-436.
6Moreland L,Gugliotti R,et al.Results of a phase-Ⅰ/Ⅱrandomized,masked,placebo-controlled trial of recombinant human interleukin 11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis.Arthritis Res,2001,3:247-252.
7Milman E,Berdon W E,et al.Periostitis secondary to interleukin-11 (Oprelvekin,Neumega).Treatment for thrombocytopenia in pediatric patients.Pediatr Radiol,2003,33:450-452.
8Lawitz E J,Hepburn M J,Casey T J.A pilot study of interleukin-11 in subjects with chronic hepatitis C and advanced liver disease nonresponsive to antiviral therapy.Am J Gastroenterol,2004,99:2359-2364.
9Ong JP,Younossi Z M.Managing the hematologic side effects of antiviral therapy for chronic hepatitis C:anemia,neutropenia,and thrombocytopenia.Cleve Clin J Med,2004,71 Suppl 3:S17-21.
10Maeshima K,Takahashi T,et al.A protective role of interleukin 11 on hepatic injury in acute endotoxemia.Shock,2004,21:134-138.
